Anne-Laurence Le Faou1,2, Ingrid Allagbé1,2, Guillaume Airagnes1,3,4,5, Monique Baha1, Abdelali Boussadi6,7, Frédéric Limosin1,4,8. 1. Department of Psychiatry and Addictology, AP-HP. Centre, Université de Paris, Paris, France. 2. Fédération Hospitalo-Universitaire, Network of Research in Substance Use Disorder, AP-HP, Paris, France. 3. Faculté de Médecine, Université Paris Descartes, Sorbonne Paris Cité, Paris, France. 4. Population-based Epidemiological Cohorts, Inserm, UMS 011, Villejuif, France. 5. Aging and chronic diseases, Inserm, UMR 1168, VIMA, Villejuif, France. 6. Département d'informatique médicale, AP-HP. Centre, Université de Paris, Paris, France. 7. INSERM UMRs 1138, Paris, France. 8. Centre Psychiatrie et Neurosciences, Inserm, U894, Paris, France.
Abstract
Background: In France, daily smoking has been highly prevalent among low-income smokers. Objectives: Our aim was to search for factors associated with both continued abstinence and attempting to quit among low-income disabled smokers. Methods: From the French national smoking cessation cohort CDT-net, we included 1624 adults living with disability pension or disabled adult allowance. Our dependent variables (abstainers, attempting to quit among non-abstainers) were used in logistic regressions. Continued abstinence was defined as self-reports of no smoking for more than 28 days and attempting to quit was defined as self-reports of no smoking for less than 28 days; both validated with carbon monoxide < 10 ppm. Results: The average age was 48.5 years, with a predominance of men (55.5%). Achieved continued abstinence was 29.9% and was positively associated with age ≥ 55, history of previous attempts, low-dependence, and number of consultations during follow-up (all p < .05). Depression history, anxiety symptoms and cannabis use were negatively associated with continued abstinence (p < .05). Quit attempts were associated with lower dependence and number of consultations during follow-up. Pharmacological treatments prescribed at inception did not contribute to improve continued abstinence rates but varenicline was found to increase quit attempts unless the number of prescriptions was scarce. Conclusion: Even among low-income disabled smokers, achieving continued abstinence and attempting to quit could be promoted with similar predictors than among affluent smokers. Treatment of anxiety symptoms and specific support for smokers with a depression history could be included in the follow-up of quit attempts.
Background: In France, daily smoking has been highly prevalent among low-income smokers. Objectives: Our aim was to search for factors associated with both continued abstinence and attempting to quit among low-income disabled smokers. Methods: From the French national smoking cessation cohort CDT-net, we included 1624 adults living with disability pension or disabled adult allowance. Our dependent variables (abstainers, attempting to quit among non-abstainers) were used in logistic regressions. Continued abstinence was defined as self-reports of no smoking for more than 28 days and attempting to quit was defined as self-reports of no smoking for less than 28 days; both validated with carbon monoxide < 10 ppm. Results: The average age was 48.5 years, with a predominance of men (55.5%). Achieved continued abstinence was 29.9% and was positively associated with age ≥ 55, history of previous attempts, low-dependence, and number of consultations during follow-up (all p < .05). Depression history, anxiety symptoms and cannabis use were negatively associated with continued abstinence (p < .05). Quit attempts were associated with lower dependence and number of consultations during follow-up. Pharmacological treatments prescribed at inception did not contribute to improve continued abstinence rates but varenicline was found to increase quit attempts unless the number of prescriptions was scarce. Conclusion: Even among low-income disabled smokers, achieving continued abstinence and attempting to quit could be promoted with similar predictors than among affluent smokers. Treatment of anxiety symptoms and specific support for smokers with a depression history could be included in the follow-up of quit attempts.
Authors: Han-Nu-Ri Kang; Kang-Sook Lee; JuYeon Koh; YuJin Park; HyunKyung Shin Journal: Int J Environ Res Public Health Date: 2021-03-29 Impact factor: 3.390